Artiva Biotherapeutics Cash Flow Statement 2023-2025 | ARTV

Fifteen years of historical annual cash flow statements for Artiva Biotherapeutics (ARTV).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023
$-65.37$-28.72
$2.43$2.27
$8.24$7.30
$10.67$9.57
$1.03$-0.51
$0$0
$0.52$-0.41
$-1.22$-26.45
$-0.33$-28.28
$-55.03$-47.43
$-0.64$-3.26
$0$0
$0$0
$-119.82$-22.72
$0$0
$-119.82$-22.72
$0$0
$-120.46$-25.98
$-0.15$24.39
$0$0
$-0.15$24.39
$167$0.00
$167$0.00
$0$0
$-4.18$0
$162$24.39
$-13.27$-49.01
$6.98$7.05
$0$0